Prophylactic treatment of endotoxic shock with monophosphoryl lipid A in newborn rats

Biology of the Neonate

Volumn 77, Issue 3, 2000, Pages 191-195

  Wy, Cherry Ann ^a   Goto, Masakatsu ^a   Young, Rita I ^a   Myers, Thomas F ^a   Muraskas, Jonathan ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Endotoxic shock; Lactate; Monophosphoryl lipid A; Prophylaxis; Sepsis; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; LACTIC ACID; PHOSPHORYL LIPID A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE SEPSIS; LACTATE BLOOD LEVEL; MORTALITY; NEWBORN; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SALMONELLA ENTERITIDIS; SEPTIC SHOCK;

ENTERITIDIS; NEGIBACTERIA; SALMONELLA ENTERITIDIS;

EID: 0034065124     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014215     Document Type: Article

References (23)

1. Goto M, Yoshioka T, Young R, Battelino T, Anderson C, Zeller WP: A sublethal dose of LPS to pregnant rats induces TNF-α tolerance in their 0-day-old offspring. Am J Physiol 1997;273:1158-1162.
2. Henricson B, Benjamin W, Vogel S: Differential cytokine induction by doses of LPS and MPL-A that result in early endotoxin tolerance. Infect Immun 1990;58:2429-2437.
3. Takayama K, Qureshi N, Ribi E, Cantrell JL: Separation and characterization of toxic and nontoxic forms of lipid A. Rev Infect Dis 1984; 6:439-443.
4. Madonna G, Peterson J, Ribi E, Vogel S: Early-phase endotoxin tolerance: Induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect Immun 1986;52:6-11.
5. Carpati C, Astiz M, Rackow E, Kim J, Yoon K, Weil M: MPL attenuates the effects of endotoxic shock in pigs. J Lab Clin Med 1992;119: 346-353.
6. Astiz M, Rackow E, Kim Y, Weil M: Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia. Circ Shock 1991;3:92-97.
7. Gustafson G, Rhodes M, Hegel T: MPL as a prophylactic for sepsis and septic shock. Prog Clin Biol Res 1995;392:567-579.
8. Astiz M, Rackow EC, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R, Stern W: Pretreatment of normal humans with monophosphoryllipid A induces tolerance to endotoxin. A prospective, double-blind, randomized, controlled trial. Crit Care Med 1995:23:9-17.
9. Ribi E: Beneficial modification of the endotoxin molecule. J Biol Response Modif 1984;3:1-9.
10. Fitzgerald M, Goto M, Myers T, Zeller P: Early metabolic effects of sepsis in preterm infants. J Pediatr 1992;121:951-955.
11. Freminet A, Bursaux E, Poyart CF: Effect of elevated lactataemia on the rates of lactic turnover and oxidation in rats. Pflugers Arch 1974; 346:75-86.
12. Astiz M, Saha D, Brooks K, Carpati C, Rackow E: Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock 1993;39:194-198.
13. Rudbach J, Myers K, Rechtman DJ, Ulrich C: Prophylactic use of MPL in patients at risk for sepsis: in Levin J (ed): Gram-Negative Sepsis: Basic Science to Clinical Intervention. New York. Wiley-Liss. 1994, pp 107-124.
14. Burrell R: Human responses to bacterial endotoxin. Circ Shock 1994;43:137-153.
15. Astiz M, Galera A, Saha D, Carpati C, Rackow E: Monophosphoryl lipid A protects against Gram-positive sepsis and tumor necrosis factor. Shock 1994;2:271-274.
16. Yao Z, Foster P, Gross G: Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravaseular coagulation. Circ Shock 1994;43:107-114.
17. Proctor R, Will J, Burhop K, Raetz C: Protection of mice against lethal endotoxemia by lipid A precursor. Infect Immun 1986;52:905-907.
18. Johnston CA, Greisman SE: Mechanism ot endotoxin tolerance: in Handbook of Endotoxin. Amsterdam, Elsevier Science, 1985, vol 2: Pathophysiology of Endotoxin, edited by Hinshaw LB, pp 359-401.
19. Yoshioka T, Goto M, Kodama M. Gottschalk M. Anderson C. Young R, Zeller WP: J5 prevents endotoxic shock in suckling rats. Res Commun Chem Pathol Pharmacol 1993;80: 367-370.
20. Berg D, Kuhn R, Rajewsky K, Muller W, Menon S. Davidson N, Grunig G, Rennick D: Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995;9: 2339-2347.
21. Huhn R. Radwanski E, Gallo J, Affrime M, Sabo R, Gonyo G, Monge A, Cutler D: Pharmacodynamics of subcutaneous recombinant inlerleukin-10 in healthy volunteers. Clin Pharmacol Ther 1997;62:171-180.
22. Balland A, Krasts D, Hoch K, Gerhart M, Stremler K, Waugh S: Characterization of the microheterogeneities of PIXY321, a genetically engineered granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein expressed in yeast. Eur J Biochem 1998;251: 812-820.
23. Bachmaier K, Pummerer C, Kozieradzki I. Pfeffer K, Mak T, Neu N, Penninger M: Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997;95:655-661.